FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898206877> ?p ?o ?g. }

• W2898206877 endingPage "e000440" @default.
• W2898206877 startingPage "e000440" @default.
• W2898206877 abstract "Patients with metastatic human epidermal growth factor receptor 2-positive breast cancer (HER2+ BC) frequently experience brain metastases (BM). We aimed to define risk factors for the development of BM in patients with HER2+ BC and to report on their outcome.This is a retrospective analysis of patients diagnosed with HER2+ BC between January 2000 and December 2014 at Institut Jules Bordet, Belgium. Statistical analyses were conducted with SAS V.9.4 using Kaplan-Meier method and Cox regression analyses.A total of 483 patients were included of whom 108 (22.4%) developed metastases and 52 (10.8%) BM. Among 96 metastatic patients without BM at diagnosis, 40 (41.7%) developed BM in the course of their disease. In multivariate analysis, risk factors for the development of BM were age ≤40 years (HR 2.10, 95 % CI 1.02 to 4.36), tumour size >2 cm (HR 4.94, 95% CI 1.69 to 14.47), nodal involvement (HR 3.48, 95% CI 1.47 to 8.25), absence or late start (≥6 months after initial diagnosis) of adjuvant anti-HER2 treatment (HR 3.79, 95% CI 1.52 to 9.43 or HR 2.65, 95% CI 1.03 to 6.82) and the development of lung metastases as first site of relapse (HR 6.97, 95% CI 3.41 to 14.24). Twenty-two patients with HER2+ BC and BM sent to our institute for further treatment were included in the outcome analysis. Asymptomatic patients at the time of BM diagnosis showed a better overall survival than symptomatic patients (HR 0.49, 95% CI 0.25 to 0.94).A considerable number of patients with metastatic HER2+ BC will develop BM. Screening of patients with risk factors for BM might lead to early detection and better outcome. However, randomised controlled trials examining the use of MRI as a screening method for BM in patients with metastatic BC are warranted before such an approach can be recommended." @default.
• W2898206877 created "2018-11-02" @default.
• W2898206877 creator A5010064853 @default.
• W2898206877 creator A5034980760 @default.
• W2898206877 creator A5041670801 @default.
• W2898206877 creator A5057557133 @default.
• W2898206877 creator A5080757112 @default.
• W2898206877 creator A5081647883 @default.
• W2898206877 creator A5081663693 @default.
• W2898206877 creator A5086534207 @default.
• W2898206877 creator A5087380706 @default.
• W2898206877 date "2018-01-01" @default.
• W2898206877 modified "2023-10-06" @default.
• W2898206877 title "Risk factors for the development of brain metastases in patients with HER2-positive breast cancer" @default.
• W2898206877 cites W1755920412 @default.
• W2898206877 cites W1892496998 @default.
• W2898206877 cites W1925211454 @default.
• W2898206877 cites W1999476814 @default.
• W2898206877 cites W2006154529 @default.
• W2898206877 cites W2013073222 @default.
• W2898206877 cites W2019987300 @default.
• W2898206877 cites W2022071203 @default.
• W2898206877 cites W2063083613 @default.
• W2898206877 cites W2063376924 @default.
• W2898206877 cites W2076209903 @default.
• W2898206877 cites W2077847653 @default.
• W2898206877 cites W2095156669 @default.
• W2898206877 cites W2098460073 @default.
• W2898206877 cites W2101979288 @default.
• W2898206877 cites W2116760308 @default.
• W2898206877 cites W2118600577 @default.
• W2898206877 cites W2130327416 @default.
• W2898206877 cites W2130900820 @default.
• W2898206877 cites W2137156235 @default.
• W2898206877 cites W2138001521 @default.
• W2898206877 cites W2141393790 @default.
• W2898206877 cites W2141590659 @default.
• W2898206877 cites W2143037181 @default.
• W2898206877 cites W2143184226 @default.
• W2898206877 cites W2144686284 @default.
• W2898206877 cites W2152121934 @default.
• W2898206877 cites W2155073814 @default.
• W2898206877 cites W2158789700 @default.
• W2898206877 cites W2162155075 @default.
• W2898206877 cites W2162887147 @default.
• W2898206877 cites W2168167705 @default.
• W2898206877 cites W2200233258 @default.
• W2898206877 cites W2291927913 @default.
• W2898206877 doi "https://doi.org/10.1136/esmoopen-2018-000440" @default.
• W2898206877 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6212674" @default.
• W2898206877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30425844" @default.
• W2898206877 hasPublicationYear "2018" @default.
• W2898206877 type Work @default.
• W2898206877 sameAs 2898206877 @default.
• W2898206877 citedByCount "22" @default.
• W2898206877 countsByYear W28982068772019 @default.
• W2898206877 countsByYear W28982068772020 @default.
• W2898206877 countsByYear W28982068772021 @default.
• W2898206877 countsByYear W28982068772022 @default.
• W2898206877 countsByYear W28982068772023 @default.
• W2898206877 crossrefType "journal-article" @default.
• W2898206877 hasAuthorship W2898206877A5010064853 @default.
• W2898206877 hasAuthorship W2898206877A5034980760 @default.
• W2898206877 hasAuthorship W2898206877A5041670801 @default.
• W2898206877 hasAuthorship W2898206877A5057557133 @default.
• W2898206877 hasAuthorship W2898206877A5080757112 @default.
• W2898206877 hasAuthorship W2898206877A5081647883 @default.
• W2898206877 hasAuthorship W2898206877A5081663693 @default.
• W2898206877 hasAuthorship W2898206877A5086534207 @default.
• W2898206877 hasAuthorship W2898206877A5087380706 @default.
• W2898206877 hasBestOaLocation W28982068771 @default.
• W2898206877 hasConcept C121608353 @default.
• W2898206877 hasConcept C126322002 @default.
• W2898206877 hasConcept C143998085 @default.
• W2898206877 hasConcept C2775930923 @default.
• W2898206877 hasConcept C2777910003 @default.
• W2898206877 hasConcept C2778164965 @default.
• W2898206877 hasConcept C2779013556 @default.
• W2898206877 hasConcept C38180746 @default.
• W2898206877 hasConcept C50382708 @default.
• W2898206877 hasConcept C530470458 @default.
• W2898206877 hasConcept C71924100 @default.
• W2898206877 hasConcept C90924648 @default.
• W2898206877 hasConceptScore W2898206877C121608353 @default.
• W2898206877 hasConceptScore W2898206877C126322002 @default.
• W2898206877 hasConceptScore W2898206877C143998085 @default.
• W2898206877 hasConceptScore W2898206877C2775930923 @default.
• W2898206877 hasConceptScore W2898206877C2777910003 @default.
• W2898206877 hasConceptScore W2898206877C2778164965 @default.
• W2898206877 hasConceptScore W2898206877C2779013556 @default.
• W2898206877 hasConceptScore W2898206877C38180746 @default.
• W2898206877 hasConceptScore W2898206877C50382708 @default.
• W2898206877 hasConceptScore W2898206877C530470458 @default.
• W2898206877 hasConceptScore W2898206877C71924100 @default.
• W2898206877 hasConceptScore W2898206877C90924648 @default.
• W2898206877 hasIssue "6" @default.
• W2898206877 hasLocation W28982068771 @default.
• W2898206877 hasLocation W28982068772 @default.

• next